NL7102519A - - Google Patents

Info

Publication number
NL7102519A
NL7102519A NL7102519A NL7102519A NL7102519A NL 7102519 A NL7102519 A NL 7102519A NL 7102519 A NL7102519 A NL 7102519A NL 7102519 A NL7102519 A NL 7102519A NL 7102519 A NL7102519 A NL 7102519A
Authority
NL
Netherlands
Application number
NL7102519A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7102519A publication Critical patent/NL7102519A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NL7102519A 1970-03-05 1971-02-25 NL7102519A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1698270A 1970-03-05 1970-03-05

Publications (1)

Publication Number Publication Date
NL7102519A true NL7102519A (cg-RX-API-DMAC7.html) 1971-09-07

Family

ID=21780073

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7102519A NL7102519A (cg-RX-API-DMAC7.html) 1970-03-05 1971-02-25

Country Status (14)

Country Link
US (1) US3681349A (cg-RX-API-DMAC7.html)
AT (1) AT305288B (cg-RX-API-DMAC7.html)
BE (1) BE763745A (cg-RX-API-DMAC7.html)
CH (1) CH555343A (cg-RX-API-DMAC7.html)
DE (1) DE2110445C3 (cg-RX-API-DMAC7.html)
DK (1) DK127427B (cg-RX-API-DMAC7.html)
ES (1) ES388780A1 (cg-RX-API-DMAC7.html)
FR (1) FR2085673B1 (cg-RX-API-DMAC7.html)
GB (1) GB1294626A (cg-RX-API-DMAC7.html)
IL (1) IL36189A0 (cg-RX-API-DMAC7.html)
NL (1) NL7102519A (cg-RX-API-DMAC7.html)
NO (1) NO130728C (cg-RX-API-DMAC7.html)
SE (1) SE376420B (cg-RX-API-DMAC7.html)
ZA (1) ZA71928B (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL39003A (en) * 1971-03-25 1975-02-10 Morton Norwich Products Inc 1-(substituted benzyl)tetrahydro-2-(1h)-pyrimidones and their preparation
US3957785A (en) * 1971-12-02 1976-05-18 Societa' Farmaceutici Italia S.P.A. Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives
US3956325A (en) * 1974-01-21 1976-05-11 Smithkline Corporation 5-Heterocyclic-1,2,3,6-tetrahydro-4(5H) pyrimidinone
US4003900A (en) * 1976-03-11 1977-01-18 Morton-Norwich Products, Inc. 1-Benzyl-5-chloro-2-(1H)-pyrimidone
US4002627A (en) * 1976-03-26 1977-01-11 Morton-Norwich Products, Inc. 1-Benzyl-3-methyl-3,4,5,6-tetrahydro-2(1H) pyrimidone
US4052399A (en) * 1976-09-13 1977-10-04 Morton-Norwich Products, Inc. 1-[2-(Hexahydro-1H-azepino)ethyl]-2(1H)pyrimidone dihydrochloride
US4052400A (en) * 1976-10-29 1977-10-04 Morton-Norwich Products, Inc. Hypertensive 1-substituted 2(1h)-pyrimidones
US8835426B2 (en) * 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
ATE554078T1 (de) * 2007-07-26 2012-05-15 Vitae Pharmaceuticals Inc Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
WO2009075835A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceutical, Inc CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
JP5490020B2 (ja) 2008-01-24 2014-05-14 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状カルバゼート及びセミカルバジドインヒビター
JP5734666B2 (ja) * 2008-02-11 2015-06-17 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の1,3−オキサアゼパン−2−オン及び1,3−ジアゼパン−2−オン阻害剤
EP2254872A2 (en) * 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
JP5538356B2 (ja) * 2008-03-18 2014-07-02 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
US8592410B2 (en) 2008-05-01 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
AU2009241727B2 (en) 2008-05-01 2013-05-02 Vitae Pharmaceuticals, Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CL2009001058A1 (es) * 2008-05-01 2010-09-10 Vitae Pharmaceuticals Inc Compuestos derivados de oxazinas sustituidas, inhibidores de la 11b-hidroxiesteroide deshidrogenasa de tipo-1; composicion farmaceutica; y uso del compuesto para inhibir la actividad de 11b-hsd1, como en el tratamiento de la diabetes, dislipidemia, hipertension, obesidad, cancer, glaucoma, entre otras.
CA2723032A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5379160B2 (ja) * 2008-07-25 2013-12-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
CA2729998A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2729993A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
CA2744946A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
MA33216B1 (fr) 2009-04-30 2012-04-02 Boehringer Ingelheim Int Inhibiteurs cycliques de la 11béta-hydroxysteroïde déshydrogénase 1
GEP20156309B (en) * 2009-04-30 2015-07-10 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2440537A1 (en) 2009-06-11 2012-04-18 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
JP5749263B2 (ja) 2009-07-01 2015-07-15 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
US8552212B2 (en) 2009-11-05 2013-10-08 Boehringer Ingelheim International Gmbh Chiral phosphorus ligands
UY33001A (es) 2009-11-06 2011-05-31 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina
JP2013531636A (ja) 2010-05-26 2013-08-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 2−オキソ−1,2−ジヒドロピリジン−4−イルボロン酸誘導体
JP5860042B2 (ja) 2010-06-16 2016-02-16 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用
JP5813106B2 (ja) 2010-06-25 2015-11-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE562987A (cg-RX-API-DMAC7.html) * 1956-12-05
DE1121617B (de) * 1959-05-26 1962-01-11 Huels Chemische Werke Ag Verfahren zur Herstellung von Tetrahydropyrimidin-2-onderivaten
DE1545601A1 (de) * 1965-07-22 1969-08-07 Basf Ag Verfahren zur Herstellung von Hexahydro-pyrimidinderivaten
DE1670368A1 (de) * 1966-07-16 1970-11-05 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung aralkylsubstituierter Lactame und Cyclischer Harnstoffe
DE1670241A1 (de) * 1967-07-01 1971-01-28 Basf Ag Verfahren zur Herstellung von 2-Oxohexahydropyrimidinen

Also Published As

Publication number Publication date
AT305288B (de) 1973-02-26
DK127427B (da) 1973-11-05
DE2110445A1 (de) 1971-11-04
CH555343A (de) 1974-10-31
GB1294626A (en) 1972-11-01
SE376420B (cg-RX-API-DMAC7.html) 1975-05-26
NO130728B (cg-RX-API-DMAC7.html) 1974-10-21
ZA71928B (en) 1972-09-27
BE763745A (fr) 1971-09-03
ES388780A1 (es) 1975-03-01
DE2110445B2 (de) 1974-10-10
FR2085673A1 (cg-RX-API-DMAC7.html) 1971-12-31
DE2110445C3 (de) 1975-05-28
NO130728C (cg-RX-API-DMAC7.html) 1975-01-29
IL36189A0 (en) 1971-04-28
FR2085673B1 (cg-RX-API-DMAC7.html) 1974-09-06
US3681349A (en) 1972-08-01

Similar Documents

Publication Publication Date Title
AR204384A1 (cg-RX-API-DMAC7.html)
ATA96471A (cg-RX-API-DMAC7.html)
AU1146470A (cg-RX-API-DMAC7.html)
AU1473870A (cg-RX-API-DMAC7.html)
AU2044470A (cg-RX-API-DMAC7.html)
AU1833270A (cg-RX-API-DMAC7.html)
AU2085370A (cg-RX-API-DMAC7.html)
AU2017870A (cg-RX-API-DMAC7.html)
AU1336970A (cg-RX-API-DMAC7.html)
AU1716970A (cg-RX-API-DMAC7.html)
AU2130570A (cg-RX-API-DMAC7.html)
AU1517670A (cg-RX-API-DMAC7.html)
AU1326870A (cg-RX-API-DMAC7.html)
AR195465A1 (cg-RX-API-DMAC7.html)
AU1591370A (cg-RX-API-DMAC7.html)
AU1083170A (cg-RX-API-DMAC7.html)
AU1328670A (cg-RX-API-DMAC7.html)
AU1343870A (cg-RX-API-DMAC7.html)
AU1277070A (cg-RX-API-DMAC7.html)
AU2144270A (cg-RX-API-DMAC7.html)
AU2131570A (cg-RX-API-DMAC7.html)
AU2130770A (cg-RX-API-DMAC7.html)
AU1247570A (cg-RX-API-DMAC7.html)
AU1581370A (cg-RX-API-DMAC7.html)
AU1235770A (cg-RX-API-DMAC7.html)